Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia

98

Citations

17

References

2012

Year

Eric J. Feldman, Jonathan E. Kolitz, J M Trang, Barry D. Liboiron, Christine E. Swenson, Michael Chiarella, L.D. Mayer, Arthur C. Louie, Jeffrey E. Lancet

Leukemia Research

Pharmaceutical ScienceAdvanced LeukemiaMedicineMolar Ratio FormulationPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmacokinetics

References

	Year	Citations

Page 1

Page 1